Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion: Study Protocol for a Prospective, Open Label, Single-Center Study With 12 Months of Follow-Up.

Front Neurol · 2022 · PMC9289167 · PMID 35860483

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A post hoc analysis showed a trend in favor of Cerebrolysin in patients with severe stroke (NIHSS >12) with a significant difference in favorable NIHSS change from baseline (OR 1.27; CI lower bound, 0.97, p = 0.04).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.